The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
about
Molecular mechanisms of ETS transcription factor-mediated tumorigenesisKey tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.Controlled expression of Drosophila homeobox loci using the Hostile takeover system.MicroRNA signatures in B-cell lymphomas.Context-specific roles for paracrine IL-6 in lymphomagenesis.Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expressionGenes Involved in Maintaining the Bone Marrow Stroma Are Dysregulated in Patients with Myelofibrosis: Lenalidomide Treatment Up-regulates SOCS3Upregulation of Human ST8Sia VI (α2,8-Sialyltransferase) Gene Expression by Physcion in SK-N-BE(2)-C Human Neuroblastoma Cells.Analysis of chromatin-state plasticity identifies cell-type-specific regulators of H3K27me3 patterns.Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways.Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes.PAX genes in childhood oncogenesis: developmental biology gone awry?The role of Pax5 in leukemia: diagnosis and prognosis significance.Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Chronic lymphocytic leukemia: Time to go past genomics?The molecular pathogenesis of chronic lymphocytic leukaemia.Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell Line.Functions of the multi-interacting protein KIDINS220/ARMS in cancer and other pathologies.An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis.Chronic lymphocytic leukaemiaNon-coding recurrent mutations in chronic lymphocytic leukaemiaActivating PAX gene family paralogs to complement PAX5 leukemia driver mutations
P2860
Q26829833-B2202B9B-A6EE-433B-8DFF-E2B637FE6EA8Q34084254-466AD3E8-CB65-4108-A1F2-785C9ED955F8Q34846466-56A52883-F600-4A30-B1E5-44E78E43E493Q35049225-D3136F84-7DFB-4D58-8CF9-E221C00D4109Q35311162-9E1D8DE3-0C08-41CB-845F-36301782BE77Q35665874-F265D8D5-1FAA-4CAD-A4F4-337975E409B1Q35783359-D8A33F04-E3F2-4983-A6DD-DF9C6D715613Q36162671-D0CBA04E-7515-4021-A536-12C87398EB10Q36797506-A5EA70D8-9CC2-4FFB-AF06-1ED2548D1456Q37019322-1720837A-4BC8-443A-9143-2AEE529F60F7Q37209960-B6A5FE7C-1A22-41D9-9EE0-8870E73D7666Q37519632-4697CA31-113F-401D-9DBC-75A5A37E3E87Q37569928-C4F7BC18-C399-4FC6-B883-7E12FCFD0DBBQ37707044-68C41679-19B2-4F72-9E93-BB42ECA83696Q38231866-10D17C68-A583-4512-8B30-4C66712F774DQ38271843-F5263B54-6DAF-4B08-BF76-891643C45BFDQ38318104-8309A786-497C-4CF8-ACA3-EBE30F7465EEQ38708220-0F7AC102-B9EF-4D95-95CF-73459B3FAE5EQ38748645-762D0124-D8E0-4E13-8F47-F828D62FFDD1Q39101593-6F1E85AB-F52F-463F-9F71-0B946EFBC0EDQ41583854-F3FEF7CB-EA31-4BF8-AFB2-AFCDA1817924Q42318005-2937387B-38D7-4C76-99D7-C4D4AD40FD3AQ47357228-717B27DE-670A-4941-BFB9-D85B3217794EQ47945450-74EF7CD5-F48F-4D0F-B85B-5F9D7C7528ECQ48209946-C1521DDF-4050-43E6-8F58-6C0C65E5CCADQ55177192-12D6697B-8031-455C-9BD7-14EDBB2E6BEEQ56270980-96953CDF-EB75-4B5C-BF5B-F44567A1C657Q56996904-3CA152AF-E678-42D7-AD51-6B6CCC674085Q58739187-C5AC37E8-C692-4BFC-A547-DD33FDFF309A
P2860
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@ast
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@en
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@nl
type
label
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@ast
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@en
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@nl
prefLabel
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@ast
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@en
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@nl
P2093
P3181
P1433
P1476
The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease
@en
P2093
G. A. Robichaud
P. O'Brien
R. J. Ouellette
P304
P3181
P356
10.1158/0008-5472.CAN-11-1874
P407
P577
2011-12-15T00:00:00Z